title: Dinutuximab and Panobinostat.
abstract: The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.
authors.affiliation: Dr. Chasick is a Clinical Pharmacy Specialist for Oncology and Bone Marrow Transplant at Ochsner Medical Center in New Orleans, Louisiana .
authors.forename: Ashley
authors.initials: A
authors.lastname: Chasick
authors.affiliation: Dr. Chasick is a Clinical Pharmacy Specialist for Oncology and Bone Marrow Transplant at Ochsner Medical Center in New Orleans, Louisiana .
authors.forename: Dominic A
authors.initials: DA
authors.lastname: Solimando
authors.affiliation: Dr. Chasick is a Clinical Pharmacy Specialist for Oncology and Bone Marrow Transplant at Ochsner Medical Center in New Orleans, Louisiana .
authors.forename: J Aubrey
authors.initials: JA
authors.lastname: Waddell